TL;DR: Aetna, a CVS Health company, modified CPB 0007 — its coverage policy for erectile dysfunction and Peyronie's disease — with an effective date of March 7, 2026. Here's what billing teams need to know before submitting claims.
This update to the Aetna erectile dysfunction coverage policy touches procedures that already carry high prior authorization scrutiny and frequent claim denial rates. The policy does not list specific CPT or HCPCS codes in the data available at publication. Billing teams who treat this as a low-stakes administrative update will get caught short.
| Field | Detail |
|---|---|
| Payer | Aetna, a CVS Health company |
| Policy | Erectile Dysfunction and Peyronie's Disease — CPB 0007 |
| Policy Code | CPB 0007 |
| Change Type | Modified |
| Effective Date | 2026-03-07 |
| Impact Level | High |
| Specialties Affected | Urology, men's health, primary care, pain management (Peyronie's) |
| Key Action | Review your prior authorization workflows and medical necessity documentation against the updated CPB 0007 criteria before submitting claims on or after March 7, 2026 |
Aetna Erectile Dysfunction and Peyronie's Disease Coverage Criteria and Medical Necessity Requirements 2026
CPB 0007 is Aetna's clinical policy bulletin governing coverage for erectile dysfunction (ED) and Peyronie's disease treatments. It covers a wide spectrum — from oral pharmacotherapy to penile prostheses, vacuum erection devices, intralesional injections, and surgical correction. The policy's scope is broad, which is exactly what makes updates to it consequential.
The real issue with ED and Peyronie's billing under any payer is medical necessity documentation. Aetna has historically required that conservative treatment failure be well-documented before approving more invasive or costly interventions. That pattern almost certainly continues in this revision.
For Peyronie's disease specifically, Aetna's coverage policy has drawn a hard line between acute-phase management and chronic-phase surgical correction. Treatments like intralesional collagenase clostridium histolyticum injections have had narrow covered indications tied to specific plaque characteristics and curvature thresholds. If this modification touches those criteria, your urology billing team needs to know immediately.
Prior authorization requirements for penile prostheses and surgical correction procedures remain standard under Aetna's approach to this condition. Don't assume the modification loosened those requirements — changes to CPB 0007 have historically tightened criteria or added new documentation thresholds, not relaxed them.
Aetna Erectile Dysfunction and Peyronie's Disease Exclusions and Non-Covered Indications
Aetna has consistently classified several approaches in this clinical space as experimental or investigational. Low-intensity extracorporeal shockwave therapy (Li-ESWT) for ED has sat in the experimental bucket under prior versions of CPB 0007. If this modification changed that designation, it would be significant news for urology practices. The available policy data does not confirm a change to that status, so treat it as still non-covered until you verify against the current policy text.
Platelet-rich plasma (PRP) injections for ED and penile rejuvenation procedures fall squarely in Aetna's experimental and investigational category. No version of CPB 0007 has covered these, and nothing in the modification data suggests that changed.
Testosterone therapy for ED without documented hypogonadism has also historically been excluded. The clinical logic is that ED secondary to low testosterone requires treatment of the underlying condition — not standalone coverage of the ED presentation. Billing testosterone treatment under an ED diagnosis without the hypogonadism documentation is a fast path to claim denial.
Vacuum erection devices have historically been covered only with documented psychogenic or organic ED and failure of or contraindication to pharmacotherapy. If your team bills durable medical equipment (DME) for these devices, confirm the updated criteria before March 7, 2026.
Coverage Indications at a Glance
The specific policy data available at publication does not include indication-level criteria text from the modified CPB 0007. The table below reflects Aetna's known historical coverage framework for this policy area. Verify each row against the current CPB 0007 text at the Aetna source before billing.
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Penile prosthesis implantation (organic ED, failed conservative tx) | Covered (criteria-based) | Not listed in available data | Prior auth required; failure of pharmacotherapy must be documented |
| Vacuum erection device (organic or psychogenic ED) | Covered (criteria-based) | Not listed in available data | DME billing; contraindication to or failure of pharmacotherapy required |
| Intralesional collagenase injection for Peyronie's disease | Covered (criteria-based) | Not listed in available data | Curvature and plaque criteria apply; prior auth typically required |
| Surgical correction for Peyronie's disease (chronic phase) | Covered (criteria-based) | Not listed in available data | Stable disease required; acute phase exclusion applies |
| Low-intensity extracorporeal shockwave therapy (Li-ESWT) for ED | Experimental / Not Covered | Not listed in available data | Verify if this status changed in the March 2026 modification |
| PRP injections for ED or penile rejuvenation | Experimental / Not Covered | Not listed in available data | No coverage under any prior version of CPB 0007 |
| Testosterone therapy for ED without hypogonadism diagnosis | Not Covered | Not listed in available data | Hypogonadism must be documented as primary diagnosis |
| Oral pharmacotherapy (PDE5 inhibitors) for ED | Variable by plan | Not listed in available data | Pharmacy benefit — check individual plan; not always a medical benefit |
Aetna Erectile Dysfunction and Peyronie's Disease Billing Guidelines and Action Items 2026
The effective date of March 7, 2026 is the trigger. Any claim for services rendered on or after that date should reflect the updated CPB 0007 criteria. Here's what to do now.
| # | Action Item |
|---|---|
| 1 | Pull the current CPB 0007 text directly from Aetna. The modification is live as of March 7, 2026. Read the full policy at the Aetna source and compare it line-by-line against what your team has been using. Do not rely on summaries — including this one — as a substitute for the source document. |
| 2 | Audit your prior authorization workflows for penile prostheses and Peyronie's procedures. These are the highest-dollar services under this coverage policy and carry the most prior auth complexity. Confirm your team's PA request documentation matches the new criteria. An outdated auth request is a denial waiting to happen. |
| 3 | Update your medical necessity documentation templates. If your practice uses templated clinical notes or standardized language to support ED and Peyronie's claims, those templates need to reflect the March 2026 criteria. Specifically, document conservative treatment history, failure or contraindication to prior therapies, and diagnosis specificity. |
| 4 | Check your DME billing process for vacuum erection devices. If you bill durable medical equipment for VEDs through Aetna, confirm the updated coverage criteria still align with your current ordering and documentation workflow. Reimbursement for DME claims often lags behind when criteria change. |
| 5 | Flag claims for services rendered close to the March 7, 2026 effective date. Claims for services on March 6 fall under the prior policy. Claims for March 7 fall under the modified one. If you're billing across that boundary, make sure your team knows which criteria apply to which date of service. |
| 6 | Check Li-ESWT coverage status for any active or pending Aetna patients. If your practice offers low-intensity shockwave therapy for ED, this is the one area where the modification could have materially changed reimbursement. Confirm the current experimental designation before providing service and billing. If Aetna moved this out of experimental status, that's a significant shift in erectile dysfunction billing for urology practices. |
| 7 | Talk to your compliance officer if you're unsure how the modifications apply to your patient mix. CPB 0007 covers a wide range of services with varying coverage tiers. If your practice has volume across multiple service types — pharmacotherapy, devices, surgery, and injections — the compliance risk compounds quickly. Get a second set of eyes on your billing guidelines before the effective date. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Erectile Dysfunction and Peyronie's Disease Under CPB 0007
The policy data available for this modification does not include specific CPT, HCPCS, or ICD-10 codes. Aetna did not publish a code list in the data accessible at publication.
This is not unusual for CPB updates — Aetna sometimes modifies criteria language without simultaneously publishing an updated code appendix. It does not mean codes are unaffected. Your billing team should pull the complete CPB 0007 document from Aetna's clinical policy bulletin library and identify the applicable codes directly.
For reference, erectile dysfunction and Peyronie's disease procedures typically span surgical CPT codes for penile prosthesis implantation, HCPCS codes for DME (vacuum erection devices), injection procedure codes, and ICD-10-CM diagnosis codes in the N52 (male erectile dysfunction) and N48.6 (Peyronie's disease) families. Do not bill these codes based on this general guidance — verify every code against the current CPB 0007 text and your payer contract.
If Aetna publishes a revised code list as part of this modification, we will update this post. Check the source policy at app.payerpolicy.org/p/aetna/0007 for the most current version.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.